QM/MM Simulations of Afatinib-EGFR Addition: The Role of β-Dimethylaminomethyl Substitution
Journal of Chemical Theory and Computation · 2024
DOI: 10.1021/acs.jctc.4c00290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Theory and Computation, 2024. Verfasst von Shuhua Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Jess and Mildred Fisher College of Science and Mathematics, Towson University, Towson, Maryland 21252, United States. Hauptthemen laut MEDLINE: ErbB Receptors, Afatinib, Quantum Theory, Molecular Dynamics Simulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Center for Cancer Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Jess and Mildred Fisher College of Science and Mathematics, Towson University, Towson, Maryland 21252, United States.
- Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States.
ORCID-Profile: Shuhua Ma, Craig A Peeples, Jana Shen
Förderung
- NCI NIH HHS
- Center for Cancer Research
Zitieren
APA
Ma, S., Patel, H., Peeples, C. A., & Shen, J. (2024). QM/MM Simulations of Afatinib-EGFR Addition: The Role of β-Dimethylaminomethyl Substitution. Journal of Chemical Theory and Computation. https://doi.org/10.1021/acs.jctc.4c00290
Vancouver
Ma S, Patel H, Peeples CA, Shen J. QM/MM Simulations of Afatinib-EGFR Addition: The Role of β-Dimethylaminomethyl Substitution. Journal of Chemical Theory and Computation. 2024. doi:10.1021/acs.jctc.4c00290
BibTeX
@article{Ma2024,
author = {Ma, Shuhua and Patel, Heeral and Peeples, Craig A and Shen, Jana},
title = {QM/MM Simulations of Afatinib-EGFR Addition: The Role of β-Dimethylaminomethyl Substitution},
journal = {Journal of Chemical Theory and Computation},
year = {2024},
doi = {10.1021/acs.jctc.4c00290}
}
EUVIMED